IP Library Granted Patent US 9,943,076
Granted Patent B2
US 9,943,076 · App. 14/913,354 · Granted Apr 17, 2018

Boron added cell cryopreservation medium

Inventors: Fikrettin Sahin (Istanbul, TR); Selami Demirci (Istanbul, TR); Aysegul Dogan (Istanbul, TR)
Assignee: YEDITEPE ÜNIVERSITESI
A01N1/0221A01N1/021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,943,076
App. No.
14/913,354
Granted
Apr 17, 2018
Kind
B2
Abstract

The present invention relates to a cryopreservation (freezing) medium which can be used for long-term storage of cell lines, tissue samples, sperms, oocytes and embryos. The invention enables to freeze and store cells without affecting cell viability, to increase cell viability and to protect multipotent properties of the cells. The invention facilitates freezing and storing sperms, eggs, embryos, plant cells and materials, cancer and sensitive cell lines, stem cells (embryonic and mesenchymal), blood and blood cells and biological material and organs.

Claims (14)

1. A cryopreservation medium comprising:

20 μg/ml sodium pentaborate pentahydrate (NaB);

20% fetal bovine serum (FBS);

1% of penicillin streptomycin amphotericin (PSA) and

10%, 7%, 5% or 3% dimethyl sulfoxide (Me2SO).

2. A storage method using a cryopreservation medium, the method comprising the following steps:

1) adding 10%, 7%, 5% or 3% dimethyl sulfoxide (Me2SO) to a medium comprising 20% fetal bovine serum (FBS), 1% penicillin streptomycin amphotericin (PSA) and 20 μg/ml sodium pentaborate pentahydrate (NaB) to obtain the cryopreservation medium;

2) placing a sample to be stored into a freezing tube;

3) freezing the freezing tube to −80° C.; and

4) further freezing the freezing tube to −196° C.

3. The storage method according to claim 2 , wherein the sample in step 2) is selected from a group consisting of pancreatic islets, skin, cornea, cardiac valves, veins, blood and blood cells, umbilical cord blood and tissue, and organ and tissue pieces.

4. The storage method according to claim 2 , wherein the sample in step 2) is selected from a group consisting of hematopoietic stem cells, mesenchymal stem cells, embryonic stem cells and induced pluripotent stem cells (IPS cells).

5. The storage method according to claim 2 , wherein the sample in step 2) is selected from a group consisting of cancer cells, primary cell lines and immortalized cell lines.

6. The storage method according to claim 2 , wherein the sample in step 2) is selected from a group consisting of human and animal sperms, eggs, testicle and ovarian tissues.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2016
From: SAHIN, FIKRETTIN; DEMIRCI, SELAMI; DOGAN, AYSEGUL
To: YEDITEPE ÜNIVERSITESI
Reel/Frame 037781/0719 →
Priority Claims (1)
TR a 2013 09923 · Aug 20, 2013 · national
Continuity (1)
Related Publication 20160205922A1 · Jul 21, 2016